Sirio Pharma Co., Ltd. (SHE:300791)

Sirio Pharma Revenue

Sirio Pharma had revenue of 1.00B CNY in the quarter ending March 31, 2026, with 5.15% growth. This brings the company's revenue in the last twelve months to 4.31B, up 2.33% year-over-year. In the year 2025, Sirio Pharma had annual revenue of 4.26B with 1.23% growth.

• Revenue (ttm): 4.31B
• Revenue Growth: +2.33%
• P/S Ratio: 1.29
• Revenue / Employee: 1.55M
• Employees: 2,776
• Market Cap: 5.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.26B	51.84M	1.23%
Dec 31, 2024	4.21B	629.04M	17.56%
Dec 31, 2023	3.58B	1.07B	42.87%
Jan 1, 2023	2.51B	138.31M	5.84%
Dec 31, 2021	2.37B	302.13M	14.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error